Vistra Corp
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
VST$131.18-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| VISTRA CORP.CONSOLIDATED STATEMENTS OF CASH FLOWS(Millions of Dollars) | |||
|---|---|---|---|
| Year Ended December 31, | |||
| 2024 | 2023 | 2022 | |
| Cash flows — operating activities: | |||
| Net income (loss) | $2,812 | $1,492 | $(1,210) |
| Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 2,631 | 1,956 | 2,047 |
| Deferred income tax expense (benefit), net | 607 | 457 | (359) |
| Gain on sale of land | — | (95) | (8) |
| Impairment of long-lived and other assets | — | 49 | 74 |
| Unrealized net (gain) loss from mark-to-market valuations of commodities | (1,155) | (490) | 2,510 |
| Unrealized net (gain) loss from mark-to-market valuations of interest rate swaps | (53) | 36 | (250) |
| Unrealized net gain from nuclear decommissioning trusts | (116) | — | — |
| Change in asset retirement obligation liability | 38 | 27 | 13 |
| Asset retirement obligation accretion expense | 114 | 34 | 34 |
| Impacts of Tax Receivable Agreement | 5 | 164 | 128 |
| Gain on TRA repurchase and tender offers | (10) | (29) | — |
| Bad debt expense | 183 | 164 | 179 |
| Stock-based compensation | 100 | 77 | 63 |
| Other, net | (89) | 103 | (71) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable — trade | (242) | 214 | (852) |
| Inventories | (31) | (174) | 36 |
| Accounts payable — trade | 19 | (350) | 94 |
| Commodity and other derivative contractual assets and liabilities | (175) | 82 | (228) |
| Margin deposits, net | 842 | 1,899 | (1,874) |
| Uplift securitization proceeds receivable from ERCOT | — | — | 544 |
| Accrued interest | (18) | 46 | 16 |
| Accrued taxes | (1) | 5 | (8) |
| Accrued employee incentive | 8 | 58 | 21 |
| Asset retirement obligation settlement | (88) | (81) | (87) |
| Major plant outage deferral | (91) | (32) | 20 |
| Other — net assets | (616) | 84 | (17) |
| Other — net liabilities | (111) | (243) | (330) |
| Cash provided by operating activities | 4,563 | 5,453 | 485 |
| Cash flows — investing activities: | |||
| Capital expenditures, including nuclear fuel purchases and LTSA prepayments | (2,078) | (1,676) | (1,301) |
| Energy Harbor acquisition (net of cash acquired) | (3,065) | — | — |
| Proceeds from sales of nuclear decommissioning trust fund securities | 2,216 | 601 | 670 |
| Investments in nuclear decommissioning trust fund securities | (2,239) | (624) | (693) |
| Proceeds from sales of environmental allowances | 773 | 500 | 1,275 |
| Purchases of environmental allowances | (1,226) | (1,071) | (1,303) |
| Proceeds from sales of property, plant, and equipment, including nuclear fuel | 196 | 115 | 78 |
| Proceeds from sales of transferable ITCs | 150 | — | — |
| VISTRA CORP.CONSOLIDATED STATEMENTS OF CASH FLOWS(Millions of Dollars) | |||
|---|---|---|---|
| Year Ended December 31, | |||
| 2024 | 2023 | 2022 | |
| Other, net | (3) | 10 | 35 |
| Cash used in investing activities | (5,276) | (2,145) | (1,239) |
| Cash flows — financing activities: | |||
| Issuances of long-term debt | 3,817 | 2,498 | 1,498 |
| Repayments/repurchases of debt | (2,287) | (33) | (251) |
| Net borrowings (repayments) under accounts receivable financing | 750 | (425) | 425 |
| Borrowings under Revolving Credit Facility | 50 | 100 | 1,750 |
| Repayments under Revolving Credit Facility | (50) | (350) | (1,500) |
| Borrowings under Commodity-Linked Facility | 1,802 | — | 3,150 |
| Repayments under Commodity-Linked Facility | (1,802) | (400) | (2,750) |
| Debt issuance costs | (76) | (59) | (31) |
| Stock repurchases | (1,266) | (1,245) | (1,949) |
| Dividends paid to common stockholders | (305) | (313) | (302) |
| Dividends paid to preferred stockholders | (173) | (150) | (151) |
| Dividends paid to noncontrolling and redeemable noncontrolling interest holders | (180) | — | — |
| Payment for acquisition of noncontrolling interest | (1,748) | — | — |
| TRA Repurchase and tender offer — return of capital | (122) | — | — |
| Other, net | (14) | 83 | 31 |
| Cash used in financing activities | (1,604) | (294) | (80) |
| Net change in cash, cash equivalents and restricted cash | (2,317) | 3,014 | (834) |
| Cash, cash equivalents and restricted cash — beginning balance | 3,539 | 525 | 1,359 |
| Cash, cash equivalents and restricted cash — ending balance | $1,222 | $3,539 | $525 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.